Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?

AIMS: To evaluate rates of vitreous relapse among retinoblastoma patients treated with primary chemotherapy and assess diode laser as a potential risk factor for relapse. METHODS: Retrospective review of all patients treated with primary chemotherapy at a large ocular oncology centre. Eyes that deve...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Gombos, D S, Cauchi, P A, Hungerford, J L, Addison, P, Coen, P G, Kingston, J E
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Group 2006
Assuntos:
Clinical Science - Extended Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1857400/
https://ncbi.nlm.nih.gov/pubmed/16707528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjo.2006.091223
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados